It is clear that the current healthcare system in the US is a failure, and sadly, middle class families are usually those who are the hardest hit. We need to not only scrap Obamacare, but replace it with a sound alternative, such as the American Health Care Reform Act of 2015. This new healthcare system should foster a more competitive insurance market by allowing individuals and companies to purchase plans across state lines, thereby driving the cost down for consumers. We also need to be doing all we can to support and enable innovation in healthcare—such as health apps, telehealth, and new devices. These technologies would increase access to healthcare services, and would increase quality by providing physicians and patients with more information to make better decisions.
More on Healthcare
Washington, D.C.— Congressman Tom Marino (R-PA-10) issued the following statement after requesting that President Donald Trump withdraw his name from consideration to lead the Office of National Drug Control Policy (ONDCP):
“Today I informed President Donald Trump of my intent to withdraw my name from any further consideration to lead ONDCP.
Washington, D.C.—Tomorrow at 1:00 p.m. Congressman Tom Marino (PA-10) will hold a hearing on anticompetitive behavior and the health care marketplace.
Washington, D.C.--Today, the U.S. Food and Drug Administration (FDA) held a public meeting to solicit input in areas where the FDA’s rules are being used in ways that create obstacles and delays. FDA Commissioner Scott Gottlieb, M.D., has shown a commitment to ensuring that generic manufacturers have access to promote competition.
Washington, D.C. -- Congressman Tom Marino (PA-10) and Congressman John Lewis (GA-05) reintroduced H.R. 2644, the Chronic Kidney Disease Improvement in Research and Treatment Act of 2017. This bill is aimed at improving the lives of those suffering with kidney disease by identifying barriers for transplantation and improving donation rates.
Washington D.C. – Today, Congressman Tom Marino (PA-10) and Congressman James P. McGovern (MA-02), co-chairs of the Congressional Cystic Fibrosis Caucus, introduced H.Con.Res. 58, a bipartisan resolution to recognize May as Cystic Fibrosis Awareness Month. This resolution recognizes the Cystic Fibrosis community for their dedication to their patients, acknowledges the investments and scientific achievements that have improved patients’ lives, and urges researchers, developers, patients, and providers to do everything possible to find a cure for this deadly disease.
Washington D.C. – Today the U.S. House of Representatives passed H.R.1628, the American Health Care Act (AHCA) by a vote of 217-213. Congressman Tom Marino (PA-10) issued the following statement in support of the bill:
Washington, D.C. – Today, top leaders on the Senate and House Judiciary Committees led by Senator Patrick Leahy (D-VT) introduced legislation to combat anticompetitive practices used by some brand-name pharmaceutical and biologic companies to block entry of lower-cost generic drugs. The Creating and Restoring Equal Access to Equivalent Samples (CREATES) Act would deter pharmaceutical companies from blocking cheaper generic alternatives from entering the marketplace.
Washington, D.C.—Congressman Tom Marino (PA-10) released the following statement on H.Res.157, declaring the last day of February “Rare Disease Day.”:
Washington, D.C. – Congressman Tom Marino (PA-10) applauded the U.S. Senate’s passage of S.483, the Ensuring Patient Access and Effective Drug Enforcement Act of 2016. Marino was the sponsor of companion signature prescription drug diversion legislation (H.R. 471) which passed in the House on April 21, 2015.
Washington, D.C. – Today, Congressman Tom Marino (PA-10) and Congressman Peter DeFazio (OR-4) lead a bipartisan coalition of Members of Congress in sending a letter to Health and Human Services (HHS) Secretary Sylvia Burwell urging clarification of privacy and security standards for connected health technologies.